Evidence map›Paper›PMID 29554219›Full record

ArticleBrain : a journal of neurology2018

PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity.

Floriana Fruscione, Pierluigi Valente, Bruno Sterlini, Alessandra Romei, Simona Baldassari, Manuela Fadda, Cosimo Prestigio, Giorgia Giansante, Jacopo Sartorelli, Pia Rossi and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 130 citations in OpenAlex.

  1. Hemiplegic migraine: genetics and pathophysiology.The Journal of clinical investigation · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Paroxysmal kinesigenic dyskinesia: clinical report of 10 cases from three pedigrees with literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  6. Developmental, Neuroanatomical and Cellular Expression of Genes Causing Dystonia.Annals of clinical and translational neurology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Floriana FruscioneLaboratory of Neurogenetics and Neuroscience, Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16148 Genova, Italy.
Pierluigi ValenteDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Bruno SterliniDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Alessandra RomeiDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Simona BaldassariLaboratory of Neurogenetics and Neuroscience, Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16148 Genova, Italy.
Manuela FaddaDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Cosimo PrestigioDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Giorgia GiansanteDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Jacopo SartorelliLaboratory of Neurogenetics and Neuroscience, Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16148 Genova, Italy.
Pia RossiDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Alicia RubioSan Raffaele Scientific Institute and National Research Council (CNR), Institute of Neuroscience, Via Olgettina 58, 20132 Milano, Italy.
Antonio GambardellaInstitute of Neurology, University Magna Graecia, Viale Europa, 88100 Catanzaro, Italy.
Thierry NieusDepartment of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan, Milano, Italy.
Vania BroccoliSan Raffaele Scientific Institute and National Research Council (CNR), Institute of Neuroscience, Via Olgettina 58, 20132 Milano, Italy.
Anna FassioDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Pietro BaldelliDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Anna CorradiDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Federico ZaraLaboratory of Neurogenetics and Neuroscience, Istituto Giannina Gaslini, Via Gerolamo Gaslini, 5, 16148 Genova, Italy.
Fabio BenfenatiDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV, 3, 16132 Genova, Italy.
Italian Institute of Technology · ITIstituto Giannina Gaslini · ITUniversity of Genoa · ITNational Research Council · ITMagna Graecia University · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

See Lerche (doi:10.1093/brain/awy073) for a scientific commentary on this article.Proline-rich transmembrane protein 2 (PRRT2) is the causative gene for a heterogeneous group of familial paroxysmal neurological disorders that include seizures with onset in the first year of life (benign familial infantile seizures), paroxysmal kinesigenic dyskinesia or a combination of both. Most of the PRRT2 mutations are loss-of-function leading to haploinsufficiency and 80% of the patients carry the same frameshift mutation (c.649dupC; p.Arg217Profs*8), which leads to a premature stop codon. To model the disease and dissect the physiological role of PRRT2, we studied the phenotype of neurons differentiated from induced pluripotent stem cells from previously described heterozygous and homozygous siblings carrying the c.649dupC mutation. Single-cell patch-clamp experiments on induced pluripotent stem cell-derived neurons from homozygous patients showed increased Na+ currents that were fully rescued by expression of wild-type PRRT2. Closely similar electrophysiological features were observed in primary neurons obtained from the recently characterized PRRT2 knockout mouse. This phenotype was associated with an increased length of the axon initial segment and with markedly augmented spontaneous and evoked firing and bursting activities evaluated, at the network level, by multi-electrode array electrophysiology. Using HEK-293 cells stably expressing Nav channel subtypes, we demonstrated that the expression of PRRT2 decreases the membrane exposure and Na+ current of Nav1.2/Nav1.6, but not Nav1.1, channels. Moreover, PRRT2 directly interacted with Nav1.2/Nav1.6 channels and induced a negative shift in the voltage-dependence of inactivation and a slow-down in the recovery from inactivation. In addition, by co-immunoprecipitation assays, we showed that the PRRT2-Nav interaction also occurs in brain tissue. The study demonstrates that the lack of PRRT2 leads to a hyperactivity of voltage-dependent Na+ channels in homozygous PRRT2 knockout human and mouse neurons and that, in addition to the reported synaptic functions, PRRT2 is an important negative modulator of Nav1.2 and Nav1.6 channels. Given the predominant paroxysmal character of PRRT2-linked diseases, the disturbance in cellular excitability by lack of negative modulation of Na+ channels appears as the key pathogenetic mechanism.

Indexed as

AnimalsAxon Initial SegmentCell DifferentiationCerebral CortexConsanguinityFibroblastsGene Expression RegulationHEK293 CellsHumansInduced Pluripotent Stem CellsMembrane PotentialsMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMutationMembrane ProteinsNanog Homeobox ProteinNANOG protein, humanNAV1.2 Voltage-Gated Sodium ChannelNAV1.6 Voltage-Gated Sodium ChannelNerve Tissue ProteinsPAX6 Transcription FactorPRRT2 protein, humanSCN8A protein, humanSOX1 protein, humanSOXB1 Transcription Factors

Identifiers

PMID29554219
PMCPMC5888929
OpenAlexW2791846751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.